Cargando…
Bromocriptine Therapy for the Treatment of Invasive Prolactinoma: The Single Institute Experience
OBJECTIVE: The objective of this study was to describe and characterize the clinical course of treatment for invasive prolactinoma patients using bromocriptine. METHODS: The study group included 23 patients who were treated with bromocriptine for their invasive prolactinomas. Clinical histories, ser...
Autores principales: | Cho, Kyung Rae, Jo, Kyung-Il, Shin, Hyung Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Brain Tumor Society and The Korean Society for Neuro-Oncology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027106/ https://www.ncbi.nlm.nih.gov/pubmed/24904895 http://dx.doi.org/10.14791/btrt.2013.1.2.71 |
Ejemplares similares
-
Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas.
por: Missale, C., et al.
Publicado: (1995) -
Temporal resolution of idiopathic granulomatous mastitis with resumption of bromocriptine therapy for prolactinoma
por: Bouton, Marcia E., et al.
Publicado: (2015) -
Recurrent Priapism From Cabergoline and Bromocriptine in a
Hypogonadal Man With Prolactinoma
por: Menon, Lakshmi P., et al.
Publicado: (2021) -
Bromocriptine as a Potential Glucose-lowering Agent for the Treatment of Prolactinoma with Type 2 Diabetes
por: Oshige, Tamami, et al.
Publicado: (2019) -
Inhibition of SKP2 Sensitizes Bromocriptine-Induced Apoptosis in Human Prolactinoma Cells
por: Huang, Jinxiang, et al.
Publicado: (2017)